The Patient Registry Software Market Size was evaluated at USD 1.72 billion in 2022, and is predicted to increase at a CAGR of 11.9% from 2023 to 2030, to reach USD 4.23 billion by 2030.

The patient registry software market share is expected to witness significant growth in the coming years. With the increasing adoption of electronic health records (EHRs) and the need for efficient data management in healthcare organizations, patient registry software has become an essential tool.

One of the key factors driving the market share is the growing emphasis on personalized medicine and precision healthcare. Patient registries play a crucial role in collecting and analyzing patient data, enabling healthcare providers to identify patterns, trends, and outcomes related to specific diseases or conditions. This information helps in tailoring treatment plans and improving patient care.

Moreover, government initiatives promoting the use of electronic health records and interoperability are further propelling market growth. Many countries have implemented regulations mandating the use of patient registry software to ensure standardized data collection and sharing across healthcare systems. This has led to increased adoption by hospitals, clinics, research institutions, and pharmaceutical companies.

Get Report Sample @ https://www.snsinsider.com/sample-request/1786

Key Players Covered in report are: ArborMetrix, Dacima Software, IBM Corporation, FIGmd, IQVIA Holdings, Optum, Premier, Inc., McKesson Corporation, OpenText Corporation, Syneos Health, and other players.

KEY MARKET SEGMENTATION:

By Type of Registry

·         Disease Registries

·         Health Service Registries

·         Product Registries

By Functionality

·         Population Health Management (PHM)

·         Health Information Exchange (HIE)

·         Patient Care Management

·         Others

By Deployment Model

·         Cloud

·         On-Premise

By End User

·         Government Organizations & Research Centers

·         Hospitals and Clinics

·         Others

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Blog: https://healthcare-pharma-report.blogspot.com/